Wedbush Securities’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-25,108
| Closed | -$420K | – | 1048 |
|
|
2020
Q2 | $420K | Buy |
25,108
+1,418
| +6% | +$23.7K | 0.04% | 484 |
|
|
2020
Q1 | $342K | Sell |
23,690
-268
| -1% | -$3.87K | 0.04% | 482 |
|
|
2019
Q4 | $802K | Sell |
23,958
-7,496
| -24% | -$251K | 0.07% | 313 |
|
|
2019
Q3 | $659K | Buy |
31,454
+9,397
| +43% | +$197K | 0.06% | 343 |
|
|
2019
Q2 | $459K | Buy |
22,057
+10,997
| +99% | +$229K | 0.05% | 468 |
|
|
2019
Q1 | $247K | Buy |
11,060
+457
| +4% | +$10.2K | 0.03% | 679 |
|
|
2018
Q4 | $254K | Buy |
10,603
+970
| +10% | +$23.2K | 0.03% | 593 |
|
|
2018
Q3 | $263K | Sell |
9,633
-365
| -4% | -$9.97K | 0.03% | 645 |
|
|
2018
Q2 | $269K | Buy |
9,998
+824
| +9% | +$22.2K | 0.03% | 594 |
|
|
2018
Q1 | $292K | Buy |
+9,174
| New | +$292K | 0.04% | 535 |
|